Cybersecurity Training Program For Blind and Low Vision Enrollees and Using AI and OCT Scans To Detect Inflammation From Anti-VEGF Drugs

David Mayne (Novacoast - Wichita, KS)

Dr. Sudeshna Sil Kar (Emory University School of Medicine - Atlanta, GA)

 

David Mayne, program director of Novacoast's Apex Program, discusses how those who are blind or have low vision can train to be cybersecurity experts.

Then, Dr. Sudeshna Sil Kar, assistant research scientist at Emory University School of Medicine in Atlanta, explains how artificial intelligence (AI) and optical coherence tomography (OCT) scans can be used to detect inflammation resulting from the use of anti-VEGF drugs in the fight against neovascular age-related macular degeneration.

7/21/2024 Podcast (Click Image Below)

AI Being Used With Ultrasound To Treat Giant Cell Arteritis and Mesogen's Development Of RPE Patches To Potentially Treat Macular Degeneration

Dr. Jay Avasarala (University of Kentucky Medical Center - Lexington, KY)

Mesogen (The Woodlands, TX)

Dr. Jay Avasarala, professor of neurology and director of the Multiple Sclerosis and Neuroimmunology Center at the University of Kentucky Medical Center in Lexington, explains how artificial intelligence can be used with point-of-care ultrasound (POCUS) to treat Giant Cell Arteritis.

Dr. Michael Riddle, chief executive officer of Mesogen in The Woodlands, Texas, explains how bone marrow-derived stem cells can be used in retinal pigment epithelium (RPE) patches to potentially treat macular degeneration.

7/14/2024 Podcast (Click Image Below)